Tykerb Vs. Herceptin?
Phase III trial will compare lapatinib and trastuzumab in preventing recurrence of early-stage breas ... more
Predicting BC Risk
Researchers seek women between the ages of 20 and 80 at high risk or average risk of developing brea ... more
Study on Lapatinib
If you have HER2/neu positive, early-stage cancer and did not take Herceptin, you may be eligible to ... more